KR102350857B1 - 국화 및 목련 유성온천수 추출물의 유산균 발효물을 함유하는 화장료 조성물 및 그 제조방법 - Google Patents
국화 및 목련 유성온천수 추출물의 유산균 발효물을 함유하는 화장료 조성물 및 그 제조방법 Download PDFInfo
- Publication number
- KR102350857B1 KR102350857B1 KR1020190153454A KR20190153454A KR102350857B1 KR 102350857 B1 KR102350857 B1 KR 102350857B1 KR 1020190153454 A KR1020190153454 A KR 1020190153454A KR 20190153454 A KR20190153454 A KR 20190153454A KR 102350857 B1 KR102350857 B1 KR 102350857B1
- Authority
- KR
- South Korea
- Prior art keywords
- magnolia
- chrysanthemum
- cosmetic composition
- lactic acid
- hot spring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 108
- 235000007516 Chrysanthemum Nutrition 0.000 title claims abstract description 74
- 241000218378 Magnolia Species 0.000 title claims abstract description 73
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 65
- 239000000203 mixture Substances 0.000 title claims abstract description 62
- 239000002537 cosmetic Substances 0.000 title claims abstract description 58
- 241000894006 Bacteria Species 0.000 title claims abstract description 55
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 54
- 239000004310 lactic acid Substances 0.000 title claims abstract description 54
- 238000000855 fermentation Methods 0.000 title description 7
- 230000004151 fermentation Effects 0.000 title description 7
- 244000189548 Chrysanthemum x morifolium Species 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 84
- 241000723353 Chrysanthemum Species 0.000 claims abstract description 74
- 230000002087 whitening effect Effects 0.000 claims abstract description 22
- 230000006872 improvement Effects 0.000 claims abstract description 20
- 230000037303 wrinkles Effects 0.000 claims abstract description 19
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims description 22
- 238000004519 manufacturing process Methods 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 239000006071 cream Substances 0.000 claims description 9
- 240000001929 Lactobacillus brevis Species 0.000 claims description 8
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims description 8
- 244000199866 Lactobacillus casei Species 0.000 claims description 7
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 7
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 7
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 7
- 229940017800 lactobacillus casei Drugs 0.000 claims description 7
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 7
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 6
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 6
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 6
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 6
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 6
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 6
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 6
- 239000006210 lotion Substances 0.000 claims description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 5
- 241001608472 Bifidobacterium longum Species 0.000 claims description 5
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 5
- 239000012046 mixed solvent Substances 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 claims 2
- 241000186012 Bifidobacterium breve Species 0.000 claims 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 2
- 241000186660 Lactobacillus Species 0.000 claims 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 2
- 235000019437 butane-1,3-diol Nutrition 0.000 claims 2
- 229940039696 lactobacillus Drugs 0.000 claims 2
- 229960004592 isopropanol Drugs 0.000 claims 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 abstract description 19
- 230000008099 melanin synthesis Effects 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 10
- 230000005764 inhibitory process Effects 0.000 abstract description 7
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 63
- 239000000047 product Substances 0.000 description 50
- 210000003491 skin Anatomy 0.000 description 18
- 238000012360 testing method Methods 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 15
- 238000000605 extraction Methods 0.000 description 12
- 230000008569 process Effects 0.000 description 11
- 238000002835 absorbance Methods 0.000 description 10
- 239000003963 antioxidant agent Substances 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 230000032683 aging Effects 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 7
- 230000002292 Radical scavenging effect Effects 0.000 description 5
- 102000003425 Tyrosinase Human genes 0.000 description 5
- 108060008724 Tyrosinase Proteins 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 230000009759 skin aging Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 240000002853 Nelumbo nucifera Species 0.000 description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 3
- 206010051246 Photodermatosis Diseases 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000007764 o/w emulsion Substances 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000008845 photoaging Effects 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- -1 tetrazolium salt Chemical class 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 2
- 241000132536 Cirsium Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 241000234435 Lilium Species 0.000 description 2
- 244000042664 Matricaria chamomilla Species 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 2
- 101710200814 Melanotropin alpha Proteins 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 101710147108 Tyrosinase inhibitor Proteins 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000012496 blank sample Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 239000013028 medium composition Substances 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 239000000209 sambucus canadensis extract Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 229940047670 sodium acrylate Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OCZVHBZNPVABKX-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine;ethanol Chemical compound CCO.[O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 OCZVHBZNPVABKX-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241001331134 Chrysanthemum zawadskii Species 0.000 description 1
- 235000014475 Chrysanthemum zawadskii subsp zawadskii Nutrition 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 102000006746 NADH Dehydrogenase Human genes 0.000 description 1
- 108010086428 NADH Dehydrogenase Proteins 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229940048053 acrylate Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229940056099 polyglyceryl-4 oleate Drugs 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000006318 protein oxidation Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
Abstract
본 발명의 피부미백 및 피부 주름개선용 화장료 조성물은 피부에 안전하면서도 국화 및 목련의 복합성분에 의한 상승작용으로 우수한 멜라닌생성 억제, 및 항산화 활성을 나타내므로 피부 미백, 주름개선과 탄력증진 및 노화지연에 따른 효과가 우수하다.
Description
구분 | 국화 온천수추출물(건조물 중량) | 목련 온천수 추출물(건조물 중량) |
비교예 1 | 16.4g | 14.5g |
구분 | 국화 유산균 발효물(건조물 중량) | 목련 유산균 발효물(건조물 중량) |
비교예 2 | 10.2g | 9.7g |
시료명 | 농도(ppm) | 세포생존율(%) | |
실시예1 | 국화 및 목련 복합 발효물 |
100 | 103.7 |
150 | 105.3 | ||
200 | 104.7 | ||
비교예1 | 국화 온천수 추출물 | 100 | 105.1 |
150 | 107.3 | ||
200 | 106.4 | ||
목련 온천수 추출물 | 100 | 98.8 | |
150 | 97.4 | ||
200 | 97.0 |
시료명 | 멜라닌 합성 저헤율(%) | |
실시예1 | 국화 및 목련 복합 발효물 | 49.8 |
비교예1 | 국화 온천수 추출물 | 21.4 |
목련 온천수 추출물 | 31.2 | |
비교예2 | 국화 발효물 | 32.7 |
목련 발효물 | 36.1 |
시료명 | 항산화효과 (DPPH소거 활성율,%) |
|
실시예1 | 국화 및 목련 복합 발효물 | 83.6 |
비교예1 | 국화 온천수 추출물 | 43.9 |
목련 온천수 추출물 | 35.4 | |
비교예2 | 국화 발효물 | 59.2 |
목련 발효물 | 49.5 |
조성성분 | 실시예 2 조성비(중량%) |
세토스테아릴알코올 | 3.0 |
글리세릴스테이레이트 | 2.0 |
세테아릴올리베이트, 솔비탄올리베이트 | 1.0 |
폴리글리세릴-3 메틸글루코스디스테아레이트 | 1.5 |
스큐알렌 | 5.0 |
에틸헥실올리베이트, 소듐아크릴레이트코폴리머, 폴리글리세릴-4올리에이트 | 0.5 |
아크릴레이트/C10-30알킬아크릴레이트크로스폴리머 | 0.3 |
카프릴릭/카프릭트리글리세라이드 | 5.0 |
세틸에칠헥사노에이트 | 5.0 |
디메치콘 | 0.5 |
부틸렌글리콜 | 5.0 |
글리세린 | 8.0 |
1,2헥산디올 | 2.0 |
암모니움아크롤로일디메틸타우레이트/브이피코폴리머 | 0.3 |
알지닌 | 0.3 |
소듐아크릴레이트,폴리솔베이트80 | 0.3 |
국화 및 목련 복합 유산균 발효물(실시예 1) | 5.0 |
정제수 | To 100 |
유효성분 | 조성비(화장품 조성물 총중량 기준 중량%) | |||||
비교예4 | 비교예5 | 비교예6 | 비교예7 | 비교예8 | ||
비교예1 | 국화 온천수 추출물 | 5.0 | ||||
목련 온천수 추출물 | 5.0 | |||||
비교예2 | 국화 발효추출물 | 5.0 | 1.25 | |||
목련 발효추출물 | 5.0 | 1.25 |
시료명 | 피시험자수 | 판정결과 | 자극도 | |||
- | + - | + | + + | |||
실시예2 | 20명 | 20 | 0 | - | - | 0.00 |
비교예3 | 20 | 0 | - | - | 0.00 | |
비교예4 | 20 | 0 | - | - | 0.00 | |
비교예5 | 20 | 0 | - | - | 0.00 | |
비교예6 | 19 | 1 | - | - | 0.05 | |
비교예7 | 20 | 0 | - | - | 0.00 | |
비교예8 | 20 | 0 | - | - | 0.00 | |
-:홍반이나 특이사항 없음, +-:주위보다 약간 붉어짐, +:주위보다 현저히 붉어짐 ++:주위보다 심히게 붉어지고 부풀어 오름 |
구분 | 응답자 수 | |||||
매우 악화됨 | 약간 악화됨 | 변화없음 | 약간 좋아짐 | 매우 좋아짐 | ||
피부색 변화정도 | 실시예2 | - | - | 11 | 13 | 10 |
비교예3 | - | 1 | 23 | 9 | - | |
비교예8 | - | 1 | 22 | 10 | - | |
피부 탄력감 변화정도 | 실시예2 | - | - | 5 | 24 | 5 |
비교예3 | - | - | 20 | 13 | - | |
비교예8 | - | - | 20 | 13 | - | |
피부 주름 변화 정도 |
실시예2 | - | - | 7 | 19 | 8 |
비교예3 | - | - | 19 | 14 | - | |
비교예8 | - | - | 23 | 10 | - |
Claims (9)
- 국화 1 ~ 10중량부에 대하여 목련 1 ~ 10중량부로 조합하여 온천수로 추출한 추출물의 유산균 발효물을 유효성분으로 0.01 ~ 20중량% 함유하는 것을 특징으로 하는 피부미백 및 피부주름 개선용 화장료 조성물.
- 삭제
- 삭제
- 청구항 1에 있어서, 국화 및 목련 온천수 추출물은 유성온천수 추출물이고, 유산균 발효물은 락토바실러스 카세이(Lactobacillus casei), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 브레비스(Lactobacillus brevis), 락토바실러스 플란타룸(Lactobacillus plantarum), 락토바실러스 레우트리(Lactobacillus reuteri), 비피도박테리움 비피둠(Bifidobacterium bifidum), 비포도박테리움 브레이브(Bifodobacterium breve) 및 비포도박테리움 롱검(Bifidobacterium longum)으로 이루어진 군으로부터 선택된 적어도 하나 이상의 유산균으로 발효시킨 유산균 발효물인 것을 특징으로 하는 피부미백 및 피부 주름개선용 화장료 조성물.
- 청구항 4에 있어서, 피부미백 및 피부 주름개선용 화장료 조성물이 항산화효과를 나타내는 것을 특징으로 하는 피부미백 및 피부 주름개선용 화장료 조성물.
- 청구항 1 또는 청구항 4 또는 청구항 5에 있어서, 피부미백 및 피부 주름개선용 화장료 조성물이 화장수, 로션, 영양크림, 마사지크림, 에센스, 겔, 세럼, 팩, 및 에멀젼 제형 중에서 선택되는 어느 하나의 제형인 것을 특징으로 하는 피부미백 및 피부 주름개선용 화장료 조성물.
- a). 국화 1 ~ 10중량부와 목련 1 ~ 10중량부를 조합하고 온천수 또는 온천수와 알코올의 혼합용매로 추출하여 국화 및 목련 온천수 추출물을 얻는 제1공정,
b). 상기 제1공정의 추출물을 유산균으로 발효시켜 국화 및 목련 추출물의 유산균 발효물을 얻는 제2공정 및
c). 상기 제2공정의 유산균 발효물을 화장료 조성물 총중량에 대하여 0.01 내지 20.0중량% 함유하는 화장료 조성물을 제조하는 제3공정을 포함하는 것을 특징으로 피부미백 및 피부 주름개선용 화장료 조성물의 제조방법.
- 청구항 7에 있어서, 제1공정의 온천수는 유성온천수이고, 탄소수 1 ~ 4의 저급알코올은 메탄올, 메탄올 수용액, 에탄올, 에탄올 수용액, 노말 프로판올, 이소-프로판올, 노말 부탄올, 1,3-부틸렌글리콜, 1,3-부틸렌글리콜로부터 선택되는 하나 이상의 성분인 것을 특징으로 하는 피부미백 및 피부 주름개선용 화장료 조성물의 제조방법.
- 청구항 8에 있어서, 제2공정의 유산균은 락토바실러스 카세이(Lactobacillus casei), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 브레비스(Lactobacillus brevis), 락토바실러스 플란타룸(Lactobacillus plantarum), 락토바실러스 레우트리(Lactobacillus reuteri), 비피도박테리움 비피둠(Bifidobacterium bifidum), 비포도박테리움 브레이브(Bifodobacterium breve) 및 비포도박테리움 롱검(Bifidobacterium longum)으로부터 선택된 적어도 하나 이상의 유산균인 것을 특징으로 하는 피부미백 및 피부 주름개선용 화장료 조성물의 제조방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190153454A KR102350857B1 (ko) | 2019-11-26 | 2019-11-26 | 국화 및 목련 유성온천수 추출물의 유산균 발효물을 함유하는 화장료 조성물 및 그 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190153454A KR102350857B1 (ko) | 2019-11-26 | 2019-11-26 | 국화 및 목련 유성온천수 추출물의 유산균 발효물을 함유하는 화장료 조성물 및 그 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210064818A KR20210064818A (ko) | 2021-06-03 |
KR102350857B1 true KR102350857B1 (ko) | 2022-01-14 |
Family
ID=76396639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190153454A Active KR102350857B1 (ko) | 2019-11-26 | 2019-11-26 | 국화 및 목련 유성온천수 추출물의 유산균 발효물을 함유하는 화장료 조성물 및 그 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102350857B1 (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102659125B1 (ko) | 2021-08-09 | 2024-04-23 | (주)정코스메틱 | 도고온천수를 이용하여 배양된 프로바이오틱스를 포함하는 화장료 조성물 |
CN114672519B (zh) * | 2022-02-24 | 2022-11-15 | 广州市巧美化妆品有限公司 | 裙带菜/温泉水发酵液,含其产品及其制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101595921B1 (ko) | 2014-01-17 | 2016-02-19 | 박노면 | 천연화장품 조성물의 제조방법 |
KR101991830B1 (ko) * | 2017-12-22 | 2019-09-30 | 주식회사 콧데 | 미네랄이 풍부한 온천수로 추출한 감초 및 병풀 추출물을 함유하는 화장품 조성물 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160087113A (ko) * | 2015-01-13 | 2016-07-21 | 정다운 | 꽃을 함유하는 화장품 |
KR101945862B1 (ko) | 2015-09-02 | 2019-02-11 | 대한민국 | 울릉국화 추출물을 포함하는 세포노화 억제용 조성물, 및 세포노화 억제와 주름개선 및 피부 탄력 개선을 통한 동안용 화장료 조성물 |
KR101969497B1 (ko) | 2017-06-12 | 2019-04-16 | 엘지전자 주식회사 | 그리들 장치 및 이를 구비하는 조리기기 |
KR102022216B1 (ko) | 2019-03-27 | 2019-09-17 | (주) 비즈켐 | 피토플라센타 복합 추출물을 함유하는 노화방지용 화장료 조성물 |
-
2019
- 2019-11-26 KR KR1020190153454A patent/KR102350857B1/ko active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101595921B1 (ko) | 2014-01-17 | 2016-02-19 | 박노면 | 천연화장품 조성물의 제조방법 |
KR101991830B1 (ko) * | 2017-12-22 | 2019-09-30 | 주식회사 콧데 | 미네랄이 풍부한 온천수로 추출한 감초 및 병풀 추출물을 함유하는 화장품 조성물 |
Non-Patent Citations (1)
Title |
---|
인터넷 자료(https://blog.naver.com/kthee0123/220672604091,천연화장품::우리꽃연구소 목련::천연미백크림과 스킨로션, 천연화장품추천!)* |
Also Published As
Publication number | Publication date |
---|---|
KR20210064818A (ko) | 2021-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20100135871A (ko) | 섬유모세포의 증식 및/또는 활성을 자극하는 활성 성분 | |
KR102139472B1 (ko) | 기능성 펩타이드와 발효물을 포함하는 피부노화 개선용 조성물 | |
KR102373899B1 (ko) | 피부의 주름 개선, 미백, 세포 재생, 상처 치유에 유효한 복합 천연물 추출물을 활성성분으로 함유하는 다 기능성 화장품 조성물 | |
KR102145447B1 (ko) | 비타민나무 발효물을 포함하는 화장료 조성물 | |
KR101809265B1 (ko) | 니코티노일 펩타이드 및 천연 발효물을 함유하는 화장료 조성물 | |
KR102813126B1 (ko) | 항노화제, 항산화제, 항염증제 및 미백제, 그리고 화장료 | |
KR20180038639A (ko) | 목서 발효추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR20180082056A (ko) | 천연 복합 추출물을 유효성분으로 포함하는 기능성 화장료 조성물 | |
KR102129430B1 (ko) | 기능성 펩타이드와 콜라겐 발효물을 포함하는 피부 노화 완화용 화장료 조성물 | |
KR102350857B1 (ko) | 국화 및 목련 유성온천수 추출물의 유산균 발효물을 함유하는 화장료 조성물 및 그 제조방법 | |
KR101645476B1 (ko) | 흑효모 발효를 통해 비타민 c 함량이 증가된 산자나무 발효 추출물을 함유하는 화장료 조성물 | |
KR101855207B1 (ko) | 흑효모 발효를 통해 비타민 c 함량이 증가된 카카두플럼 추출물을 함유하는 화장료 조성물 | |
KR100898311B1 (ko) | 두유 복합발효 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR101855206B1 (ko) | 장뇌삼 발효액을 포함하는 화장료 조성물 | |
KR102356339B1 (ko) | 황금 발효 추출물을 이용한 항산화 및 멜라닌색소 생성억제를 위한 화장료 조성물 | |
KR102139471B1 (ko) | 피부노화방지 및 피부주름개선용 메셈브리안테뭄속 아이스플랜트와 콜라겐의 혼합 발효물, 발효 용해물의 제조방법 및 이를 포함하는 화장료 조성물 | |
KR101843976B1 (ko) | 흑효모 발효 발아녹두 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR20210060801A (ko) | 식물 복합 발효물을 유효성분으로 포함하는 항노화 화장료 조성물 | |
KR101957435B1 (ko) | 피부 주름 예방 또는 개선용 누에고치 발효물의 제조방법 및 이를 유효성분으로 함유하는 화장료 조성물 | |
KR101854444B1 (ko) | 아티초크잎 추출물을 유효성분으로 포함하는 튼살 예방 및 개선용 화장료 조성물 | |
KR101775485B1 (ko) | 계혈등 발효 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR101997231B1 (ko) | 효소반응을 이용하여 제조된 꿀 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR101987425B1 (ko) | 갯버들 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR101658799B1 (ko) | 마태반 발효물 및 생약성분을 이용한 피부미백 화장료 조성물 | |
KR102459512B1 (ko) | 싸이클로덱스트린글루카노트란스퍼라제를 이용한 능이, 국화, 목련 복합 추출물의 제조방법 및 이를 함유하는 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20191126 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20210726 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20211215 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20220110 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20220111 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration |